This report contains general information about prostate cancer and links to review(s) describing disease models in flies. Multiple loci have been implicated in hereditary prostate cancer; many additional loci appear to confer susceptibility to the disease. Specific models developed in Drosophila are listed in the 'Related Diseases' section below.
[updated Dec. 2020 by FlyBase; FBrf0222196]
[PROSTATE CANCER](https://omim.org/entry/176807)
[MITOTIC ARREST DEFICIENT 1 LIKE 1; MAD1L1](https://omim.org/entry/602686)
[KLF TRANSCRIPTION FACTOR 6; KLF6](https://omim.org/entry/602053)
[PHOSPHATASE AND TENSIN HOMOLOG; PTEN](https://omim.org/entry/601728)
[MAX-INTERACTING PROTEIN 1; MXI1](https://omim.org/entry/600020)
[BRCA2 DNA REPAIR-ASSOCIATED PROTEIN; BRCA2](https://omim.org/entry/600185)
[ZINC FINGER HOMEOBOX 3; ZFHX3](https://omim.org/entry/104155)
[CHECKPOINT KINASE 2; CHEK2](https://omim.org/entry/604373)
Prostate cancer is the most common cancer in American men and is usually very slowly progressive; it is diagnosed in an estimated 80% of men who reach age 80 (http://www.webmd.com/prostate-cancer; 2016.12.20).
Prostatic adenocarcinoma is the most frequent form of prostate cancer and accounts for 90 to 95% of prostate cancer. Prostatic adenocarcinoma occurs in the cells lining the glandular organ of the prostate, the area responsible for the secretion of the chemicals that make up a large portion of seminal fluid. Typically, prostatic adenocarcinoma is a slow growing form of cancer. (American Cancer Society; http://www.crs-src.ca/page.aspx?pid=1801; 2016.12.20)